Table 1

Patient demographics

Characteristics
Gender
 Male/female (no. of patients)17/10
Median age (range)54 (36–87)
Stage at entry (no. of patients)
 III, free of disease10
 III, active disease2 (skin only)
 IV, free of disease8
 IV, active disease7
Median KPS (range)90 (80–100)
Prior therapy (no. of patients)
 None8
 IFN-α11
 Chemotherapy7
 Interleukin-23
 Vaccine4
 Levamisole2
 Intralesional DNCB1
 Tamoxifen1